Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |